Panbela Therapeutics, Inc. Interest Expense Nonoperating
Panbela Therapeutics, Inc. reported Interest Expense Nonoperating of $442.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2024-11-14
- Panbela Therapeutics, Inc. interest expense nonoperating for the quarter ending 2024-09-30 was $442.00K, a 522.54% increase year-over-year.
- Panbela Therapeutics, Inc. interest expense nonoperating for the quarter ending 2024-06-30 was $59.00K, a 15.71% decline year-over-year.
- Panbela Therapeutics, Inc. interest expense nonoperating for the quarter ending 2023-09-30 was $71.00K.
- Panbela Therapeutics, Inc. interest expense nonoperating for the quarter ending 2023-06-30 was $70.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month |
|---|---|---|---|
| 2024-09-30 | $442.00K 10-Q · filed 2024-11-14 | $501.00K derived: sum of 2 quarters · filed 2024-11-14 | $564.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $59.00K 10-Q · filed 2024-08-13 | $121.00K 10-Q · filed 2024-08-13 | |
| 2023-09-30 | $71.00K 10-Q · filed 2024-11-14 | $141.00K derived: sum of 2 quarters · filed 2024-11-14 | $245.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $70.00K 10-Q · filed 2024-08-13 | $173.00K 10-Q · filed 2024-08-13 |